Edward Burd

Corporate Officer/Principal bei Rebiotix, Inc.

Health Technology

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Lee Jones	F	67	Rebiotix, Inc. Rebiotix, Inc. Pharmaceuticals: MajorHealth Technology Rebiotix, Inc. develops and commercializes medical therapies. It offers human microbiome, clostridium difficile, inflammatory bowel disease or ulcerative colitis, hepatic encephalopathy, multi-drug resistant organism, and microbiota restoration therapies. The company was founded by Lee A. Jones, Michael Berman, and Erwin A. Kelen in 2011 and is headquartered in Roseville, MN.	13 Jahre
Erwin A. Kelen	M	89	Rebiotix, Inc. Rebiotix, Inc. Pharmaceuticals: MajorHealth Technology Rebiotix, Inc. develops and commercializes medical therapies. It offers human microbiome, clostridium difficile, inflammatory bowel disease or ulcerative colitis, hepatic encephalopathy, multi-drug resistant organism, and microbiota restoration therapies. The company was founded by Lee A. Jones, Michael Berman, and Erwin A. Kelen in 2011 and is headquartered in Roseville, MN.	13 Jahre
William W. McGuire	M	74	Rebiotix, Inc. Rebiotix, Inc. Pharmaceuticals: MajorHealth Technology Rebiotix, Inc. develops and commercializes medical therapies. It offers human microbiome, clostridium difficile, inflammatory bowel disease or ulcerative colitis, hepatic encephalopathy, multi-drug resistant organism, and microbiota restoration therapies. The company was founded by Lee A. Jones, Michael Berman, and Erwin A. Kelen in 2011 and is headquartered in Roseville, MN.	11 Jahre
Erik Dubberke	M	-	Rebiotix, Inc. Rebiotix, Inc. Pharmaceuticals: MajorHealth Technology Rebiotix, Inc. develops and commercializes medical therapies. It offers human microbiome, clostridium difficile, inflammatory bowel disease or ulcerative colitis, hepatic encephalopathy, multi-drug resistant organism, and microbiota restoration therapies. The company was founded by Lee A. Jones, Michael Berman, and Erwin A. Kelen in 2011 and is headquartered in Roseville, MN.	-
Ed Kuijper	M	-	Rebiotix, Inc. Rebiotix, Inc. Pharmaceuticals: MajorHealth Technology Rebiotix, Inc. develops and commercializes medical therapies. It offers human microbiome, clostridium difficile, inflammatory bowel disease or ulcerative colitis, hepatic encephalopathy, multi-drug resistant organism, and microbiota restoration therapies. The company was founded by Lee A. Jones, Michael Berman, and Erwin A. Kelen in 2011 and is headquartered in Roseville, MN.	-
Thomas Louie	M	-	Rebiotix, Inc. Rebiotix, Inc. Pharmaceuticals: MajorHealth Technology Rebiotix, Inc. develops and commercializes medical therapies. It offers human microbiome, clostridium difficile, inflammatory bowel disease or ulcerative colitis, hepatic encephalopathy, multi-drug resistant organism, and microbiota restoration therapies. The company was founded by Lee A. Jones, Michael Berman, and Erwin A. Kelen in 2011 and is headquartered in Roseville, MN.	-